Clinical Trial Update: Effect of BM-MSCs on Early Graft Function Recovery After DCD Kidney Transplant. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating bone marrow-derived mesenchymal stem cells (BM-MSCs) to improve early graft function after donation after circulatory deat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tubular Necrosis

Drugs mentioned

• BM-MSCs (bone marrow-derived mesenchymal stem cells) (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Kidney Transplantation, Acute Kidney Tubular Necrosis | Phase 1, Phase 2 | Status: UNKNOWN